T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines-Reference-Cited by-同舟云学术

T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines

Published:2023-09 Issue: Volume:217 Page:105688
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Li Mengling,Chen Cen,Wang Xialin,Guo Pengju,Feng Helong,Zhang Xueqi,Zhang Wanpo,Gu Changqin,Zhu Jingen,Wen Guoyuan,Feng Yaoyu,Xiao Lihua^ORCID,Peng Guiqing,Rao Venigalla B.,Tao Pan^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference69 articles.

1. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns;Bachmann;Nat. Rev. Immunol.,2010

2. Bacteriophage adhering to mucus provide a non-host-derived immunity;Barr;Proc. Natl. Acad. Sci. U.S.A.,2013

3. Protective intranasal immunization against influenza virus in infant mice is dependent on IL-6;Bonney;Front. Immunol.,2020

4. Activation-induced markers detect vaccine-specific CD4⁺ T cell responses not measured by assays conventionally used in clinical trials;Bowyer;Vaccines 6,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza A Vaccine Candidates Based on Virus-like Particles Formed by Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465;Vaccines;2024-09-09

2. Mucosal vaccines for viral diseases: Status and prospects;Virology;2024-05

3. Recombinant bacteriophage T4 displaying key epitopes of the foot-and-mouth disease virus as a novel nanoparticle vaccine;International Journal of Biological Macromolecules;2024-02